Skip to main content
VCbacked
Log inGet Started

Azalea Therapeutics

Berkeley, United States

Azalea Therapeutics is a biotechnology company with a primary focus on developing cancer immunotherapies.

$65.0M raised
Nov 2025
Series A
BiotechnologyInformation TechnologyMedicalProduct Research

Top Investors

HS Chau Women in Enterprising Science programRA Capital ManagementYosemiteSozo VenturesThird Rock Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Azalea Therapeutics

How much funding has Azalea Therapeutics raised?
Azalea Therapeutics has raised $65.0M in total funding. The most recent round was Series A. The last funding was announced in November 2025.
Who are Azalea Therapeutics's investors?
Azalea Therapeutics's investors include HS Chau Women in Enterprising Science program, RA Capital Management, Yosemite, Sozo Ventures, Third Rock Ventures.
Where is Azalea Therapeutics headquartered?
Azalea Therapeutics is headquartered in Berkeley, United States.
What does Azalea Therapeutics do?
Azalea Therapeutics is a biotechnology company with a primary focus on developing cancer immunotherapies.
What stage is Azalea Therapeutics at?
Azalea Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Azalea Therapeutics — Funding & Investors." VCBacked, November 4, 2025, https://www.vcbacked.co/company/azalea-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2025). Azalea Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/azalea-therapeutics
Wikipedia (cite web)
{{cite web |title=Azalea Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/azalea-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong